Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy [Phase 1]
Phase 1 clinical trial update assessing safety and immune response of a Mammaglobin-A DNA vaccine in breast cancer patients receiving neoadj…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Evaluation of Improved Onboard Patient Imaging
An update on a clinical trial evaluating improved onboard imaging for cancer treatment. The sponsor is Varian (a Siemens Healthineers compan…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan
Pfizer-sponsored real-world analysis in Japan used administrative claims data to characterize treatment patterns for HR+/HER2- advanced brea…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial [NA]
The MIND trial investigates a mindfulness-based program to improve nutrition among stage I–III breast cancer survivors. The study status is …
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment [Phase 3]
The Phase 3 trial evaluating ropivacaine perfusion after mastectomy versus placebo has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer
This clinical trial update describes an independent, external, blinded retrospective validation of an AI-based prognostic assay for ER-posit…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Predictive Clinical and Biological Parameters in Breast Cancer [NA]
Trial update indicates that the study NCT01521676 evaluating predictive clinical and biological parameters in breast cancer has been termina…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer [Phase 2]
Phase 2 clinical trial update assessing the combination of durvalumab with trastuzumab and pertuzumab in HER2-enriched breast cancer, with r…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer [Phase 3]
A Phase 3 clinical trial compares tucatinib versus placebo, both with trastuzumab and pertuzumab, in patients with metastatic HER2-positive …
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation [Phase 2]
Phase 2 clinical trial update for ASTRAEA investigating a combination of myeloid inhibition and radiation in metastatic triple-negative brea…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
A clinical trial update on Inavolisib evaluating its effectiveness and safety in endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-nega…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Breast Mammogram and Tissue Study
A completed clinical trial update focusing on breast mammography and tissue analysis in breast cancer.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
A long-running breast imaging study for women at high genetic risk of breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening [NA]
Completed study comparing Restriction Spectrum Imaging (RSI) to conventional and abbreviated breast MRI for breast cancer screening; results…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: SENOVIE France - Therapeutic Mobility and Breast Cancer
A completed clinical trial in France (SENOVIE) investigating therapeutic mobility and breast cancer; sponsor is Institut de Recherche pour l…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
A completed clinical trial evaluating cancer outcomes in patients treated with dapagliflozin in addition to other antidiabetic therapies.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival [Phase 4]
Phase 4 study that develops and validates a prognostic score to identify metastatic breast cancer patients who are most likely to benefit fr…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
A clinical trial investigating quality of life in breast cancer survivors who were pregnant during their treatment has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer [Phase 2]
A Phase 2 study is evaluating SDX-7320 with Eribulin for breast cancer, including metastatic triple-negative breast cancer. The trial is cur…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy [NA]
This document notes the termination of a feasibility trial evaluating a web-based app to improve adherence to endocrine therapy in hormone r…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT [Phase 1]
Phase 1 clinical trial evaluating pembrolizumab in combination with intratumoral injection of Clostridium novyi-NT across multiple cancer ty…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. [Phase 3]
Phase 3 clinical trial evaluating PF-07248144 in combination with Fulvestrant for HR-positive, HER2-negative advanced or metastatic breast c…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women [NA]
Clinical trial update reporting results for a lifestyle intervention intended to reduce breast cancer risk in normal-weight women. The study…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Evaluating Cascade Communication Methods
A completed University of Pennsylvania clinical trial evaluating cascade communication methods for individuals with BRCA1 or BRCA2 mutations…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients [NA]
The GCC 1366 trial evaluating anti-proliferative response to neoadjuvant aromatase inhibitors in overweight and obese breast cancer patients…